Biochemists at the Novartis Vaccines and Diagnostics Research Center in Siena, Italy, are processing vaccine candidates by automated purification of recombinant proteins form huge numbers of bacterial lysates on a Freedom EVO® platform, saving a lot of their time without compromising reproducibility, consistency or quality.
